{
    "eid": "2-s2.0-85086708634",
    "title": "Effect of Maintenance Intravenous Iron Treatment on Erythropoietin Dose in Chronic Hemodialysis Patients: A Multicenter Randomized Controlled Trial",
    "cover-date": "2020-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Nephrology",
            "@code": "2727",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "anemia",
        "erythropoietin",
        "ferritin",
        "hemodialysis",
        "iron"
    ],
    "authors": [
        "Paweena Susantitaphong",
        "Monchai Siribumrungwong",
        "Kullaya Takkavatakarn",
        "Kamonrat Chongthanakorn",
        "Songkiat Lieusuwan",
        "Pisut Katavetin",
        "Khajohn Tiranathanagul",
        "Sookruetai Lekhyananda",
        "Kriang Tungsanga",
        "Supat Vanichakarn",
        "Somchai Eiam-Ong",
        "Kearkiat Praditpornsilpa"
    ],
    "citedby-count": 2,
    "ref-count": 27,
    "ref-list": [
        "Correction of anemia with epoetin alfa in chronic kidney disease",
        "A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease",
        "KDIGO clinical practice guideline for anemia in chronic kidney disease",
        "Efficacy and safety of intravenous iron therapy for functional iron deficiency anemia in hemodialysis patients: a meta-analysis",
        "Intravenous versus oral iron supplementation for the treatment of anemia in CKD: an updated systematic review and meta-analysis",
        "Intravenous iron and erythropoiesis-stimulating agents in haemodialysis: a systematic review and meta-analysis",
        "Safety of intravenous iron in dialysis: a systematic review and meta-analysis",
        "Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients",
        "Impact of oxidative stress in premature aging and iron overload in hemodialysis patients",
        "Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality",
        "Kidney disease: improving global outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement",
        "Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients\u2019 Response to IV Iron with Elevated Ferritin (DRIVE) Study",
        "Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation",
        "Iron balance in hemodialysis patients",
        "FIND-CKD Study Investigators. FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia",
        "A randomized trial of intravenous and oral iron in chronic kidney disease",
        "The DOPPS practice monitor for US dialysis care: trends through August 2011",
        "Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS)",
        "Safety concerns about intravenous iron therapy in patients with chronic kidney disease",
        "Intravenous iron in patients undergoing maintenance hemodialysis",
        "Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients",
        "C-terminal fibroblast growth factor 23, iron deficiency, and mortality in renal transplant recipients",
        "Effect of ferric carboxymaltose on serum phosphate and C-terminal FGF23 levels in non-dialysis chronic kidney disease patients: post-hoc analysis of a prospective study",
        "Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses",
        "Oral iron supplementation with sodium ferrous citrate reduces the serum intact and c-terminal fibroblast growth factor 23 levels of maintenance haemodialysis patients"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60023366",
            "affilname": "Rangsit University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023366",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60008902",
            "affilname": "Charoenkrung Pracharak Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008902",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "124615020",
            "affilname": "Boonyavej Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/124615020",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "107095547",
            "affilname": "The Kidney Foundation of Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/107095547",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Fresenius Medical Care",
        "Kidney Foundation of Thailand"
    ]
}